Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001410578-25-001774
Filing Date
2025-08-14
Accepted
2025-08-14 06:50:47
Documents
60
Period of Report
2025-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q lptx-20250630x10q.htm   iXBRL 10-Q 1399514
2 EX-10.1 lptx-20250630xex10d1.htm EX-10.1 21452
3 EX-31.1 lptx-20250630xex31d1.htm EX-31.1 12508
4 EX-32.1 lptx-20250630xex32d1.htm EX-32.1 7086
5 GRAPHIC lptx-20250630xex10d1001.jpg GRAPHIC 631
6 GRAPHIC lptx-20250630xex10d1002.jpg GRAPHIC 86327
  Complete submission text file 0001410578-25-001774.txt   5764069

Data Files

Seq Description Document Type Size
7 EX-101.SCH lptx-20250630.xsd EX-101.SCH 39646
8 EX-101.CAL lptx-20250630_cal.xml EX-101.CAL 33672
9 EX-101.DEF lptx-20250630_def.xml EX-101.DEF 145543
10 EX-101.LAB lptx-20250630_lab.xml EX-101.LAB 367493
11 EX-101.PRE lptx-20250630_pre.xml EX-101.PRE 253966
63 EXTRACTED XBRL INSTANCE DOCUMENT lptx-20250630x10q_htm.xml XML 876699
Mailing Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142
Business Address 47 THORNDIKE STREET SUITE B1-1 CAMBRIDGE MA 02142 617 252 4343
LEAP THERAPEUTICS, INC. (Filer) CIK: 0001509745 (see all company filings)

EIN.: 274412575 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37990 | Film No.: 251214190
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)